Reduce dose if sleep disruption is significant
When injected systemically, BPC-157 migrates preferentially to areas of tissue damage throughout the body
Morris et al., 2021) or mitohormetic strategies at the mitochondrial level
Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R
For example, the improvements in cardiovascular outcome have been evidenced in a number of large-scale randomized controlled clinical trials on cardiovascular disease ( Figure 1 Statements Author contributions JC, AM, YW, CL, HQ, XM, HY, and LD searched the data, JC, XR, and JZ wrote the main manuscript text